The Psoriasis Pipeline

Recently, Dr. Andy Blauvelt, President of Oregon Medical Research Center (OMRC), was interviewed by the American Academy of Dermatology regarding upcoming drugs that will likely become available soon to treat psoriasis. Dr. Blauvelt, an international expert in psoriasis, has experience using all of these medications while participating in clinical trials for these drugs at OMRC. The article appeared in Dermatology World, a publication sent out to and read by most dermatologists in the country. Psoriasis Pipeline_ 08_21_DermWorld

(Article reprinted with permission from Dermatology World)